Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany - Documentation of Tofacitinib Induction and Maintenance Therapy in Conjunction With Long-term Outcome and Predictors of Response

NCT04032756 is registered in ClinicalTrials.gov with Ced Service GmbH as lead sponsor.

NCT NCT04032756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04032756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tofacitinib Registry of Patients With Ulcerative Colitis in Germany - Documentation of Tofacitinib Induction and Maintenance Therapy in Conjunction With Long-term Outcome and Predictors of Response
Lead sponsor
Ced Service GmbH
Phase
Observational
Overall status
Terminated
Start date
August 1, 2019
Completion date
November 15, 2020
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biologics, bowel disease, bowel diseases, inflammatory, ced, chronic inflammatory small bowel disease, colitis, ulcerative, tofacitiniib